journal article·2020-09Open access

Engineering of monosized lipid-coated mesoporous silica nanoparticles for CRISPR delivery

Achraf Noureddine, Angelea Maestas-Olguin, Edwin A. Saada, Annette E. LaBauve, Jacob O. Agola, Keoni E. Baty, Tamara Howard, Jennifer K. Sabo, Cindy R. Sandoval Espinoza, Jennifer A. Doudna, Joseph S. Schoeniger, Kimberly S. Butler, Oscar A. Negrete, C. Jeffrey Brinker, Rita E. Serda

Acta Biomaterialia· Volume 114

Abstract

CRISPR gene editing technology is strategically foreseen to control diseases by correcting underlying aberrant genetic sequences. In order to overcome drawbacks associated with viral vectors, the establishment of an effective non-viral CRISPR delivery vehicle has become an important goal for nanomaterial scientists. Herein, we introduce a monosized lipid-coated mesoporous silica nanoparticle (LC-MSN) delivery vehicle that enables both loading of CRISPR components [145 µg ribonucleoprotein (RNP) or 40 µg plasmid/mg nanoparticles] and efficient release within cancer cells (70%). The RNP-loaded LC-MSN exhibited 10% gene editing in both in vitro reporter cancer cell lines and in an in vivo Ai9-tdTomato reporter mouse model. The structural and chemical versatility of the mesoporous silica core and lipid coating along with framework dissolution-assisted cargo delivery open new prospects towards safe CRISPR component delivery and enhanced gene editing. STATEMENT OF SIGNIFICANCE: After the discovery of CRISPR gene-correcting technology in bacteria. The translation of this technology to mammalian cells may change the face of cancer therapy within the next years. This was first made possible through the use of viral vectors; however, such systems limit the safe translation of CRISPR into clinics because its difficult preparation and immunogenicity. Therefore, biocompatible non-viral nanoparticulate systems are required to successfully deliver CRISPR into cancer cells. The present study presents the use of biomimetic lipid-coated mesoporous silica nanoparticles showing successful delivery of CRISPR ribonucleoprotein and plasmid into HeLa cervical and A549 lung cancer cells as well as successful gene editing in mice brain.
Source: europepmc · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: CRISPR and Genetic Engineering · Virus-based gene therapy research · RNA Interference and Gene Delivery

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (34)

Show source-provided references
1. CRISPR-Cas guides the future of genetic engineering10.1126/science.aat5011 ↗
2. CRISPR/Cas9: a historical and chemical biology perspective of targeted genome engineering10.1039/C6CS00197A ↗
3. CRISPR-mediated modular RNA-guided regulation of transcription in eukaryotes10.1016/j.cell.2013.06.044 ↗
4. CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation10.1126/sciadv.1500454 ↗
5. Generation of knock-in primary human T cells using Cas9 ribonucleoproteins10.1073/pnas.1512503112 ↗
6. Monoclonal Cell Line Generation and CRISPR/Cas9 Manipulation via Single-Cell Electroporation
7. Nanoparticles for CRISPR–Cas9 delivery10.1038/s41551-017-0158-x ↗
8. Self-Assembled DNA Nanoclews for the Efficient Delivery of CRISPR-Cas9 for Genome Editing10.1002/anie.201506030 ↗
9. Direct Cytosolic Delivery of CRISPR/Cas9-Ribonucleoprotein for Efficient Gene Editing10.1021/acsnano.6b07600 ↗
10. Genome editing for cancer therapy: delivery of Cas9 Protein/sgRNA plasmid via a gold nanocluster/lipid core–shell nanocarrier
11. Systemic delivery of CRISPR/Cas9 with PEG-PLGA nanoparticles for chronic myeloid leukemia targeted therapy10.1039/C8BM00263K ↗
12. Non-Viral CRISPR/Cas Gene Editing In Vitro and In Vivo Enabled by Synthetic Nanoparticle Co-Delivery of Cas9 mRNA and sgRNA10.1002/anie.201610209 ↗
13. Endosomal Escape and Delivery of CRISPR/Cas9 Genome Editing Machinery Enabled by Nanoscale Zeolitic Imidazolate Framework10.1021/jacs.7b11754 ↗
14. Material solutions for delivery of CRISPR/Cas-based genome editing tools: current status and future outlook10.1016/j.mattod.2018.12.003 ↗
15. Mesoporous silica nanoparticles in drug delivery and biomedical applications, Nanomedicine Nanotechnology
16. Degradability and Clearance of Silicon, Organosilica, Silsesquioxane, Silica Mixed Oxide, and Mesoporous Silica Nanoparticles
17. Overcoming multidrug resistance through the synergistic effects of hierarchical pH-Sensitive, ROS-Generating Nanoreactors10.1021/acsbiomaterials.7b00569 ↗
18. Rerouting engineered metal-dependent shapes of mesoporous silica nanocontainers to biodegradable Janus-type (sphero-ellipsoid) nanoreactors for chemodynamic therapy10.1016/j.cej.2019.03.272 ↗
19. Straightforward preparation of light-actuated nanomachines for controlled drug delivery with active targeting10.1002/chem.201600870 ↗
20. Engineering of large-pore lipid-coated mesoporous silica nanoparticles for dual cargo delivery to cancer cells
21. Establishing the effects of mesoporous silica nanoparticle properties on in vivo disposition using imaging-based pharmacokinetics10.1038/s41467-018-06730-z ↗
22. Periodic mesoporous organosilicas: from simple to complex bridges; a comprehensive overview of functions, morphologies and applications10.1039/C2CS35222B ↗
23. Chemistry of mesoporous organosilica in nanotechnology: molecularly organic-inorganic hybridization into frameworks10.1002/adma.201505147 ↗
24. Controlled multiple functionalization of mesoporous silica nanoparticles: homogeneous implementation of pairs of functionalities communicating through energy or proton transfers10.1039/C5NR02620B ↗
25. Engineering of Tai Chi-like nanocarriers for varisized guests delivery and synergistic eradication of patients-derived hepatocellular carcinoma
26. Mesoporous silica nanoparticle-supported lipid bilayers (protocells) for active targeting and delivery to individual leukemia cells10.1021/acsnano.6b02819 ↗
27. Multifunctional protocells for enhanced penetration in 3d extracellular tumoral matrices10.1021/acs.chemmater.7b03128 ↗
28. Efficient genome editing in the mouse brain by local delivery of engineered Cas9 ribonucleoprotein complexes10.1038/nbt.3806 ↗
29. A robust and high-throughput Cre reporting and characterization system for the whole mouse brain10.1038/nn.2467 ↗
30. Convection Enhanced Delivery of Recombinant Adeno-associated Virus Into the Mouse Brain10.1007/978-1-4939-3271-9_21 ↗
31. Electrostatically mediated liposome fusion and lipid exchange with a nanoparticle-supported bilayer for control of surface charge, drug containment, and delivery10.1021/ja902039y ↗
32. Plasmid DNA Delivery: nanotopography Matters10.1021/jacs.7b08974 ↗
33. Overcoming the specific toxicity of large plasmids electrotransfer in primary cells in vitro10.1038/mtna.2016.4 ↗
34. Rift Valley Fever Virus Strain MP-12 Enters Mammalian Host Cells via Caveola-Mediated Endocytosis10.1128/JVI.02242-12 ↗